HII Stock Analysis: Huntington Ingalls | NYSE
Aerospace & Defense | NYSE, USA | Market Cap: 11.004m USD | 12M Return: 7.7% | US4464131063 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 140M
EPS Trend: -17.2%
Qual. Beats: 2
Rev. Trend: 85.8%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Huntington Ingalls Industries (HII) is the largest U.S. military shipbuilder, operating through three segments: Ingalls (non-nuclear ships), Newport News (nuclear-powered vessels), and Mission Technologies (advanced defense services). The company designs, builds, overhauls, and repairs a wide range of vessels for the U.S. Navy and Coast Guard, including amphibious assault ships, surface combatants, national security cutters, nuclear-powered aircraft carriers, and submarines. Beyond shipbuilding, HII provides naval nuclear support, fleet maintenance, and reactor prototype services.
In addition to its shipbuilding core, HIIs Mission Technologies segment delivers C5ISR systems, AI/ML-driven battlefield decision tools, cyberspace and electronic warfare capabilities, uncrewed autonomous systems, and critical nuclear operations support. The company has a strategic partnership with HD Hyundai Heavy Industries to integrate intelligent mechanized welding systems at its Ingalls Shipbuilding division. Founded in 1886 and headquartered in Newport News, Virginia, HII is classified within the Industrials sector (Aerospace & Defense sub-industry), with revenue heavily tied to long-term U.S. federal defense contracts.
- Columbia-class submarine construction drives Newport News backlog
- Mission Technologies segment expands on defense IT and AI demand
- Navy shipbuilding budget growth supports multi-year revenue visibility
| Net Income: 661.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA -5.83 > 1.0 |
| NWC/Revenue: 4.60% < 20% (prev 1.93%; Δ 2.67% < -1%) |
| CFO/TA 0.03 > 3% & CFO 347.0m > Net Income 661.0m |
| Net Debt (3.16b) to EBITDA (1.26b): 2.50 < 3 |
| Current Ratio: 1.23 > 1.5 & < 3 |
| Outstanding Shares: last quarter (39.5m) vs 12m ago 0.25% < -2% |
| Gross Margin: 12.56% > 18% (prev 12.38%; Δ 0.18% > 0.5%) |
| Asset Turnover: 106.4% > 50% (prev 95.63%; Δ 10.79% > 0%) |
| Interest Coverage Ratio: 9.61 > 6 (EBIT TTM 942.0m / Interest Expense TTM 98.0m) |
| A: 0.05 (Total Current Assets 3.24b - Total Current Liabilities 2.63b) / Total Assets 12.7b |
| B: 0.45 (Retained Earnings 5.73b / Total Assets 12.7b) |
| C: 0.08 (EBIT TTM 942.0m / Avg Total Assets 12.4b) |
| D: 0.72 (Book Value of Equity 5.31b / Total Liabilities 7.37b) |
| Altman-Z'' = 3.05 = A |
| DSRI: 0.28 (Receivables 746.0m/2.34b, Revenue 13.2b/11.6b) |
| GMI: 0.99 (GM 12.38% / 12.56%) |
| AQI: 0.96 (AQ_t 0.42 / AQ_t-1 0.44) |
| SGI: 1.14 (Revenue 13.2b / 11.6b) |
| TATA: 0.02 (NI 661.0m - CFO 347.0m) / TA 12.7b) |
| Beneish M = -3.55 (Cap -4..+1) = AAA |
As of October 30, 2026, the stock is trading at USD 316.21 with a total of 1,705,377 shares traded. Over the past week, the price has changed by +13.39%, over one month by +21.79%, over three months by +13.30% and over the past year by +7.72%.
Current recommended Stop Loss: 308.40 (which is 2.5% or 1.1 ATR below the current price).
Huntington Ingalls has received a consensus analysts rating of 3.92. Therefore, it is recommended to buy HII.
- StrongBuy: 5
- Buy: 1
- Hold: 6
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 356.4 | 12.7% |
P/E Trailing = 16.6424
P/E Forward = 13.0548
P/S = 0.8346
P/B = 2.0868
P/EG = 0.8622
Revenue TTM = 13.2b USD
EBIT TTM = 942.0m USD
EBITDA TTM = 1.26b USD
Long Term Debt = 2.70b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 3.17b USD (from shortLongTermDebtTotal, last quarter) + Leases 233.0m
Net Debt = 3.16b USD (calculated: Debt 3.17b - CCE 12.0m)
Enterprise Value = 14.2b USD (11.0b + Debt 3.17b - CCE 12.0m)
Interest Coverage Ratio = 9.61 (Ebit TTM 942.0m / Interest Expense TTM 98.0m)
EV/FCF = -354.0x (Enterprise Value 14.2b / FCF TTM -40.0m)
FCF Yield = -0.28% (FCF TTM -40.0m / Enterprise Value 14.2b)
FCF Margin = -0.30% (FCF TTM -40.0m / Revenue TTM 13.2b)
Net Margin = 5.01% (Net Income TTM 661.0m / Revenue TTM 13.2b)
Gross Margin = 12.56% ((Revenue TTM 13.2b - Cost of Revenue TTM 11.5b) / Revenue TTM)
Gross Margin QoQ = 13.22% (prev 13.17%)
Tobins Q-Ratio = 1.12 (Enterprise Value 14.2b / Total Assets 12.7b)
Interest Expense / Debt = 3.09% (Interest Expense 98.0m / Debt 3.17b)
Taxrate = 21.68% (183.0m / 844.0m)
NOPAT = 737.8m (EBIT 942.0m * (1 - 21.68%))
Current Ratio = 1.23 (Total Current Assets 3.24b / Total Current Liabilities 2.63b)
Debt / Equity = 0.60 (Debt 3.17b / totalStockholderEquity, last quarter 5.31b)
Debt / EBITDA = 2.50 (Net Debt 3.16b / EBITDA 1.26b)
Debt / FCF = -78.90 (negative FCF - burning cash) (Net Debt 3.16b / FCF TTM -40.0m)
Total Stockholder Equity = 5.13b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.33% (Net Income 661.0m / Total Assets 12.7b)
RoE = 12.89% (Net Income TTM 661.0m / Total Stockholder Equity 5.13b)
RoCE = 12.03% (EBIT 942.0m / Capital Employed (Equity 5.13b + L.T.Debt 2.70b))
RoIC = 7.35% (NOPAT 737.8m / Invested Capital 10.0b)
WACC = 5.85% (E(11.0b)/V(14.2b) * Re(6.84%) + D(3.17b)/V(14.2b) * Rd(3.09%) * (1-Tc(0.22)))
Discount Rate = 6.84% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -12.83 | Cagr: 0.0%
[DCF] Fair Price = unknown (Cash Flow -40.0m)
EPS Correlation: -17.21 | EPS CAGR: -2.29% | SUE: 1.38 | # QB: 2
Revenue Correlation: 85.77 | Revenue CAGR: 5.05% | SUE: 1.58 | # QB: 1
EPS current Year (2026-12-31): EPS=18.50 | Chg30d=-0.06% | Revisions=-17% | GrowthEPS=+20.2% | GrowthRev=+7.1%
EPS next Year (2027-12-31): EPS=21.01 | Chg30d=+0.85% | Revisions=+0% | GrowthEPS=+13.6% | GrowthRev=+6.4%
[Analyst] Revisions Ratio: -12% (up=2, down=3)